Givaudan SA

SWX:GIVN Stock Report

Market Cap: CHF 35.9b

Givaudan Valuation

Is GIVN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of GIVN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: GIVN (CHF3894) is trading below our estimate of fair value (CHF4111.11)

Significantly Below Fair Value: GIVN is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for GIVN?

Other financial metrics that can be useful for relative valuation.

GIVN key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue5.7x
Enterprise Value/EBITDA26.9x
PEG Ratio5.7x

Price to Earnings Ratio vs Peers

How does GIVN's PE Ratio compare to its peers?

The above table shows the PE ratio for GIVN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average27.9x
SIKA Sika
30.8x9.0%CHF 38.4b
EMSN EMS-CHEMIE HOLDING
33x8.8%CHF 15.2b
CLN Clariant
31x29.4%CHF 3.7b
HOLN Holcim
16.8x7.7%CHF 50.4b
GIVN Givaudan
34.8x6.1%CHF 35.9b

Price-To-Earnings vs Peers: GIVN is expensive based on its Price-To-Earnings Ratio (34.8x) compared to the peer average (27.9x).

Price to Earnings Ratio vs Industry

How does GIVN's PE Ratio compare vs other companies in the European Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a8.7%
 n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a8.7%
 n/an/an/a
No more companies

Price-To-Earnings vs Industry: GIVN is expensive based on its Price-To-Earnings Ratio (34.8x) compared to the European Chemicals industry average (17.8x).

Price to Earnings Ratio vs Fair Ratio

What is GIVN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

GIVN PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio34.8x
Fair PE Ratio22.9x

Price-To-Earnings vs Fair Ratio: GIVN is expensive based on its Price-To-Earnings Ratio (34.8x) compared to the estimated Fair Price-To-Earnings Ratio (22.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst GIVN forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 3,894.00
CHF 4,203.57
+7.9%
10.2%CHF 5,100.00CHF 3,330.00n/a21
Nov ’25CHF 4,133.00
CHF 4,203.57
+1.7%
10.2%CHF 5,100.00CHF 3,330.00n/a21
Oct ’25CHF 4,588.00
CHF 4,159.00
-9.4%
9.9%CHF 4,934.00CHF 3,200.00n/a22
Sep ’25CHF 4,356.00
CHF 4,094.82
-6.0%
10.9%CHF 4,852.00CHF 3,000.00n/a22
Aug ’25CHF 4,307.00
CHF 4,094.82
-4.9%
10.9%CHF 4,852.00CHF 3,000.00n/a22
Jul ’25CHF 4,302.00
CHF 3,976.95
-7.6%
11.5%CHF 4,800.00CHF 3,000.00n/a21
Jun ’25CHF 4,237.00
CHF 3,840.90
-9.3%
12.1%CHF 4,700.00CHF 2,800.00n/a21
May ’25CHF 3,946.00
CHF 3,805.00
-3.6%
11.8%CHF 4,700.00CHF 2,800.00n/a21
Apr ’25CHF 4,016.00
CHF 3,613.50
-10.0%
13.1%CHF 4,600.00CHF 2,800.00n/a21
Mar ’25CHF 3,710.00
CHF 3,404.02
-8.2%
11.1%CHF 4,160.00CHF 2,800.00n/a21
Feb ’25CHF 3,615.00
CHF 3,337.12
-7.7%
10.1%CHF 4,000.00CHF 2,750.00n/a21
Jan ’25CHF 3,484.00
CHF 3,201.78
-8.1%
10.7%CHF 4,000.00CHF 2,600.00n/a20
Dec ’24CHF 3,303.00
CHF 3,158.78
-4.4%
11.3%CHF 4,000.00CHF 2,500.00n/a20
Nov ’24CHF 3,028.00
CHF 3,167.83
+4.6%
12.4%CHF 4,100.00CHF 2,500.00CHF 4,133.0021
Oct ’24CHF 2,994.00
CHF 3,164.36
+5.7%
12.5%CHF 4,100.00CHF 2,500.00CHF 4,588.0021
Sep ’24CHF 2,929.00
CHF 3,120.98
+6.6%
13.3%CHF 4,100.00CHF 2,400.00CHF 4,356.0022
Aug ’24CHF 2,939.00
CHF 3,153.24
+7.3%
13.4%CHF 4,100.00CHF 2,400.00CHF 4,307.0023
Jul ’24CHF 2,965.00
CHF 3,142.15
+6.0%
13.2%CHF 4,100.00CHF 2,400.00CHF 4,302.0024
Jun ’24CHF 3,026.00
CHF 3,138.39
+3.7%
13.4%CHF 4,100.00CHF 2,400.00CHF 4,237.0023
May ’24CHF 3,122.00
CHF 3,138.39
+0.5%
13.4%CHF 4,100.00CHF 2,400.00CHF 3,946.0023
Apr ’24CHF 2,973.00
CHF 3,081.52
+3.7%
15.6%CHF 4,100.00CHF 2,039.40CHF 4,016.0024
Mar ’24CHF 2,821.00
CHF 3,081.02
+9.2%
15.8%CHF 4,100.00CHF 2,039.40CHF 3,710.0023
Feb ’24CHF 2,937.00
CHF 3,086.45
+5.1%
16.1%CHF 4,150.00CHF 2,039.40CHF 3,615.0023
Jan ’24CHF 2,833.00
CHF 3,207.52
+13.2%
17.4%CHF 4,200.00CHF 2,039.40CHF 3,484.0022
Dec ’23CHF 3,184.00
CHF 3,217.52
+1.1%
17.4%CHF 4,200.00CHF 2,039.40CHF 3,303.0022
Nov ’23CHF 2,942.00
CHF 3,281.28
+11.5%
18.5%CHF 4,200.00CHF 2,039.40CHF 3,028.0023

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y